Amgen Postdoctoral Fellow - Cell Line Development/Nanoscale Cell Culture Analytics in Thousand Oaks, California

The Amgen Postdoctoral Program is committed to providing future scientists with an enriched environment to inspire innovation that will contribute to the development of human therapeutics.

The Cell Line Development group is responsible for the generation of highly productive manufacturing cell lines for Amgen's rich and diverse large molecule pipeline.

We are currently employing next generation nanoscale fluidic devices to miniaturize Cell Line Development processes. This novel technology enables simultaneous isolation, culturing and analysis of thousands of clonal cells lines.

The Postdoctoral Fellow will utilize their biochemistry and immunoassay expertise and work cross functionally with groups across Amgen to develop new high throughput, nanoscale assays to enable characterization of thousands of production cells lines for cell culture performance, protein production and product quality attributes relevant to Amgen's large molecule pipeline.

The assignment length is expected to be 3 years long.

Basic Qualifications

PhD at the time of appointment

Preferred Qualifications

PhD at the time of appointment in a life science or engineering discipline

The successful candidate is a highly motivated and self-driven expert in cell biology and biochemistry with a strong publication record

Direct experience developing assays to quantify and characterize proteins

Experience with cell culture, protein purification, cytometry, micro/nanofluidic technology and or other analytical methods

Experience with data analysis and modeling

Proven experience working efficiently in a cross functional, multidiscipline team structure, and ability to execute projects independently

Amgen is an Equal Opportunity employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status.